E. Orbay Et Al. , "Addition of rosiglitazone to glimepirid and metformin combination therapy in type 2 diabetes," ENDOCRINE JOURNAL , vol.51, no.6, pp.521-527, 2004
Orbay, E. Et Al. 2004. Addition of rosiglitazone to glimepirid and metformin combination therapy in type 2 diabetes. ENDOCRINE JOURNAL , vol.51, no.6 , 521-527.
Orbay, E., Sargin, M., Sargin, H., Gozu, H., & Bayramicli, O., (2004). Addition of rosiglitazone to glimepirid and metformin combination therapy in type 2 diabetes. ENDOCRINE JOURNAL , vol.51, no.6, 521-527.
Orbay, E Et Al. "Addition of rosiglitazone to glimepirid and metformin combination therapy in type 2 diabetes," ENDOCRINE JOURNAL , vol.51, no.6, 521-527, 2004
Orbay, E Et Al. "Addition of rosiglitazone to glimepirid and metformin combination therapy in type 2 diabetes." ENDOCRINE JOURNAL , vol.51, no.6, pp.521-527, 2004
Orbay, E. Et Al. (2004) . "Addition of rosiglitazone to glimepirid and metformin combination therapy in type 2 diabetes." ENDOCRINE JOURNAL , vol.51, no.6, pp.521-527.
@article{article, author={E Orbay Et Al. }, title={Addition of rosiglitazone to glimepirid and metformin combination therapy in type 2 diabetes}, journal={ENDOCRINE JOURNAL}, year=2004, pages={521-527} }